Article


ScreenPoint closes series B investment round to accelerate growth and commercialization of its AI product Transpara™ for improving mammogram reading

31st May 2018

ScreenPoint closes series B investment round to accelerate growth and commercialization of its AI product Transpara™ for improving mammogram reading

ScreenPoint Medical announces today that it has raised €4.3 million in a new financing round to accelerate market introduction and further development of its products. The financing was led by Siemens Healthineers with additional participation of private investors.

Read the full press-release